| Serial Number | 97121020 |
| Word Mark | NKMAX |
| Filing Date | Thursday, November 11, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 22, 2023 |
| Registration Number | 7146622 |
| Registration Date | Tuesday, August 22, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 25, 2022 |
| Goods and Services | Pharmaceutical preparations for animals for regulating the immune system and treating cancer; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells for regulating the immune system and treating cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders |
| Pseudo Mark | NATURAL KILLER MAXIMIZING |
| Goods and Services | Development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology products; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 18, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, August 5, 2019 |
| First Use In Commerce Date | Monday, August 5, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 18, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, March 5, 2019 |
| First Use In Commerce Date | Tuesday, March 5, 2019 |
| Party Name | NKMAX CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Gyeonggi-do 13605 KR |
| Party Name | NKMAX CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Gyeonggi-do 13605 KR |
| Party Name | NKMAX CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Gyeonggi-do 13605 KR |
| Event Date | Event Description |
| Monday, November 15, 2021 | NEW APPLICATION ENTERED |
| Thursday, November 18, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 22, 2022 | ASSIGNED TO EXAMINER |
| Thursday, August 25, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 25, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 25, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 25, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 5, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 25, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 25, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 20, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, April 27, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, April 27, 2023 | USE AMENDMENT FILED |
| Wednesday, May 17, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 17, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, July 17, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, July 18, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, July 19, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, August 22, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 22, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Friday, December 6, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, December 6, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, December 6, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, December 6, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |